KK
IMVT icon

KLP Kapitalforvaltning’s Immunovant IMVT Stock Holding History

KLP Kapitalforvaltning’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$578K Sell
15,000
-3,900
-21% -$119K ﹤0.01% 1447
2026
Q1 		$469K Hold
18,900
– – ﹤0.01% 1453
2025
Q4 		$480K Buy
18,900
+4,400
+30% +$98.1K ﹤0.01% 1432
2025
Q3 		$234K Hold
14,500
– – ﹤0.01% 1765
2025
Q2 		$232K Sell
14,500
-4,200
-22% -$63.5K ﹤0.01% 1722
2025
Q1 		$320K Buy
18,700
+7,900
+73% +$165K ﹤0.01% 1533
2024
Q4 		$268K Buy
+10,800
New +$306K ﹤0.01% 1701

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KLP Kapitalforvaltning's IMVT Position: Q2 2026 in Review

KLP Kapitalforvaltning reduced its Immunovant (IMVT) stake by 21% in Q2 2026, selling an estimated $119K and leaving 15,000 shares worth $578K. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

KLP Kapitalforvaltning first reported a position in IMVT in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • KLP Kapitalforvaltning held 15,000 shares of Immunovant worth $578K as of Q2 2026.
  • KLP Kapitalforvaltning sold 3,900 Immunovant shares in Q2 2026, an estimated $119K.
  • Immunovant made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1447 holding.
  • KLP Kapitalforvaltning first reported a position in Immunovant in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.